|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 748 for Nr1h4

<< First    < Previous  |  Next >    Last >>
0.032s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Gene
9971 | NR1H4
Type: gene
Organism: human
•
•
•
•
•
Gene
100489310 | nr1h4
Type: gene
Organism: frog, western clawed
•
•
•
•
•
Gene
60351 | Nr1h4
Type: gene
Organism: rat
•
•
•
•
•
Gene
452162 | NR1H4
Type: gene
Organism: chimpanzee
•
•
•
•
•
Gene
612928 | NR1H4
Type: gene
Organism: dog, domestic
•
•
•
•
•
Gene
540528 | NR1H4
Type: gene
Organism: cattle
•
•
•
•
•
Gene
373902 | NR1H4
Type: gene
Organism: chicken
•
•
•
•
•
Gene
436847 | nr1h4
Type: gene
Organism: zebrafish
•
•
•
•
•
Gene
695618 | NR1H4
Type: gene
Organism: macaque, rhesus
•
•
•
•
•
Protein
Q99MT9
Organism: Mus musculus/domesticus
Length: 37  
Fragment?: true
•
•
•
•
•
Protein Coding Gene
MGI:1352464 | Nr1h4
Type: protein_coding_gene
Organism: mouse, laboratory
•
•
•
•
•
Publication
11279518 | J:68661
First Author: Shih DQ
Year: 2001
Journal: Nat Genet
Title: Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism.
Volume: 27
Issue: 4
Pages: 375-82
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6179260
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689421
Stage: TS21
Assay Id: MGI:6190938
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Nr1h4
Detected: false
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6179260
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689424
Stage: TS24
Assay Id: MGI:6190938
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Nr1h4
Detected: false
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6179260
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190938
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Nr1h4
Detected: false
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6179260
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190938
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Nr1h4
Detected: false
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6179260
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689419
Stage: TS19
Assay Id: MGI:6190938
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Nr1h4
Detected: false
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6179260
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689426
Stage: TS26
Assay Id: MGI:6190938
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Nr1h4
Detected: false
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6179260
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190938
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Nr1h4
Detected: false
Specimen Num: 7
•
•
•
•
•
Publication
31298930 | J:294051
First Author: Kim DH
Year: 2019
Journal: FASEB J
Title: Src-mediated crosstalk between FXR and YAP protects against renal fibrosis.
Volume: 33
Issue: 10
Pages: 11109-11122
•
•
•
•
•
DO Term
DOID:0070225 | progressive familial intrahepatic cholestasis 5
•
•
•
•
•
Publication
17931734 | J:129298
First Author: Kovacs P
Year: 2008
Journal: J Hepatol
Title: Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans.
Volume: 48
Issue: 1
Pages: 116-24
•
•
•
•
•
Publication
12421815 | J:81724
First Author: Lambert G
Year: 2003
Journal: J Biol Chem
Title: The farnesoid X-receptor is an essential regulator of cholesterol homeostasis.
Volume: 278
Issue: 4
Pages: 2563-70
•
•
•
•
•
Publication
19864602 | J:157174
First Author: Vavassori P
Year: 2009
Journal: J Immunol
Title: The bile acid receptor FXR is a modulator of intestinal innate immunity.
Volume: 183
Issue: 10
Pages: 6251-61
•
•
•
•
•
Publication
26505219 | J:234054
First Author: Fu T
Year: 2016
Journal: Mol Endocrinol
Title: FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
Volume: 30
Issue: 1
Pages: 92-103
•
•
•
•
•
Publication
15899888 | J:101042
First Author: Duran-Sandoval D
Year: 2005
Journal: J Biol Chem
Title: The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition.
Volume: 280
Issue: 33
Pages: 29971-9
•
•
•
•
•
Publication
22492528 | J:196833
First Author: Düfer M
Year: 2012
Journal: Diabetes
Title: Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition.
Volume: 61
Issue: 6
Pages: 1479-89
•
•
•
•
•
Publication
20573685 | J:182859
First Author: Lee FY
Year: 2010
Journal: Mol Endocrinol
Title: Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity.
Volume: 24
Issue: 8
Pages: 1626-36
•
•
•
•
•
Publication
28449117 | J:245618
First Author: Maczewsky J
Year: 2017
Journal: Endocrinology
Title: The LXR Ligand T0901317 Acutely Inhibits Insulin Secretion by Affecting Mitochondrial Metabolism.
Volume: 158
Issue: 7
Pages: 2145-2154
•
•
•
•
•
Publication
16023103 | J:100327
First Author: Cariou B
Year: 2005
Journal: FEBS Lett
Title: Transient impairment of the adaptive response to fasting in FXR-deficient mice.
Volume: 579
Issue: 19
Pages: 4076-80
•
•
•
•
•
Publication
30260705 | J:285947
First Author: Li WT
Year: 2019
Journal: FASEB J
Title: Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.
Volume: 33
Issue: 2
Pages: 2435-2450
•
•
•
•
•
Publication
24464484 | J:206661
First Author: Zhang X
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice.
Volume: 111
Issue: 6
Pages: 2277-82
•
•
•
•
•
Publication
21757002 | J:180347
First Author: Renga B
Year: 2011
Journal: Biochim Biophys Acta
Title: The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate.
Volume: 1812
Issue: 11
Pages: 1522-31
•
•
•
•
•
Publication
23395169 | J:196606
First Author: Sayin SI
Year: 2013
Journal: Cell Metab
Title: Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
Volume: 17
Issue: 2
Pages: 225-35
•
•
•
•
•
Publication
18436567 | J:136910
First Author: Wang YD
Year: 2008
Journal: Mol Endocrinol
Title: Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.
Volume: 22
Issue: 7
Pages: 1622-32
•
•
•
•
•
Publication
36803569 | J:356180
First Author: Yang G
Year: 2023
Journal: Biomark Res
Title: The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study.
Volume: 11
Issue: 1
Pages: 20
•
•
•
•
•
Publication
27758768 | J:248907
First Author: Moraes LA
Year: 2016
Journal: Arterioscler Thromb Vasc Biol
Title: Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.
Volume: 36
Issue: 12
Pages: 2324-2333
•
•
•
•
•
Publication
22540009 | J:187197
First Author: Li G
Year: 2012
Journal: PLoS One
Title: Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding.
Volume: 7
Issue: 4
Pages: e35895
•
•
•
•
•
Publication
17545158 | J:124601
First Author: Lee H
Year: 2007
Journal: J Biol Chem
Title: Regulation of the sodium/sulfate co-transporter by farnesoid X receptor alpha.
Volume: 282
Issue: 30
Pages: 21653-61
•
•
•
•
•
Publication
30635917 | J:347403
First Author: Gu M
Year: 2019
Journal: Br J Pharmacol
Title: Betulinic acid alleviates endoplasmic reticulum stress-mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice.
Volume: 176
Issue: 7
Pages: 847-863
•
•
•
•
•
Publication
25599407 | J:264484
First Author: Schittenhelm B
Year: 2015
Journal: Endocrinology
Title: Role of FXR in β-cells of lean and obese mice.
Volume: 156
Issue: 4
Pages: 1263-71
•
•
•
•
•
Publication
33767132 | J:317982
First Author: Kim DH
Year: 2021
Journal: Cell Death Dis
Title: The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD.
Volume: 12
Issue: 4
Pages: 320
•
•
•
•
•
Publication
24670636 | J:210469
First Author: Ryan KK
Year: 2014
Journal: Nature
Title: FXR is a molecular target for the effects of vertical sleeve gastrectomy.
Volume: 509
Issue: 7499
Pages: 183-8
•
•
•
•
•
Publication
37295248 | J:338329
 
First Author: Zheng Y
Year: 2023
Journal: Biomed Pharmacother
Title: Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro.
Volume: 164
Pages: 114957
•
•
•
•
•
Publication
17283114 | J:118204
First Author: Yang F
Year: 2007
Journal: Cancer Res
Title: Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
Volume: 67
Issue: 3
Pages: 863-7
•
•
•
•
•
Publication
24269813 | J:211836
First Author: Wu W
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Volume: 443
Issue: 1
Pages: 68-73
•
•
•
•
•
Publication
17426284 | J:121836
First Author: Houten SM
Year: 2007
Journal: Mol Endocrinol
Title: In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue.
Volume: 21
Issue: 6
Pages: 1312-23
•
•
•
•
•
Publication
17183066 | J:121075
First Author: Kim I
Year: 2007
Journal: Carcinogenesis
Title: Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.
Volume: 28
Issue: 5
Pages: 940-6
•
•
•
•
•
Publication
25184625 | J:221532
First Author: Swennes AG
Year: 2014
Journal: PLoS One
Title: Helicobacter hepaticus infection promotes hepatitis and preneoplastic foci in farnesoid X receptor (FXR) deficient mice.
Volume: 9
Issue: 9
Pages: e106764
•
•
•
•
•
Publication
22268101 | J:187499
First Author: Cui JY
Year: 2012
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice.
Volume: 302
Issue: 9
Pages: G979-96
•
•
•
•
•
Publication
17950284 | J:127752
First Author: Cariou B
Year: 2007
Journal: FEBS Lett
Title: FXR-deficiency confers increased susceptibility to torpor.
Volume: 581
Issue: 27
Pages: 5191-8
•
•
•
•
•
Publication
20699418 | J:169616
First Author: Wang XX
Year: 2010
Journal: Diabetes
Title: Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
Volume: 59
Issue: 11
Pages: 2916-27
•
•
•
•
•
Publication
16778009 | J:135714
First Author: Rizzo G
Year: 2006
Journal: Mol Pharmacol
Title: The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
Volume: 70
Issue: 4
Pages: 1164-73
•
•
•
•
•
Publication
23205607 | J:194178
First Author: Shimizu M
Year: 2013
Journal: Biochem J
Title: FGF19 (fibroblast growth factor 19) as a novel target gene for activating transcription factor 4 in response to endoplasmic reticulum stress.
Volume: 450
Issue: 1
Pages: 221-9
•
•
•
•
•
Publication
19910507 | J:155300
First Author: Fickert P
Year: 2009
Journal: Am J Pathol
Title: Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts.
Volume: 175
Issue: 6
Pages: 2392-405
•
•
•
•
•
Publication
19182371 | J:151031
First Author: Nomoto M
Year: 2009
Journal: Biol Pharm Bull
Title: Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor.
Volume: 32
Issue: 2
Pages: 172-8
•
•
•
•
•
Publication
30580099 | J:273480
First Author: Singh AB
Year: 2019
Journal: Biochim Biophys Acta Mol Cell Biol Lipids
Title: Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.
Volume: 1864
Issue: 3
Pages: 358-371
•
•
•
•
•
Publication
28787755 | J:244322
First Author: Xie S
Year: 2017
Journal: FEBS Lett
Title: A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism.
Volume: 591
Issue: 18
Pages: 2836-2847
•
•
•
•
•
Publication
23507574 | J:197926
First Author: Deng Y
Year: 2013
Journal: Endocrinology
Title: Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis.
Volume: 154
Issue: 5
Pages: 1794-801
•
•
•
•
•
Publication
23541942 | J:201212
First Author: Langhi C
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Regulation of N-Myc downstream regulated gene 2 by bile acids.
Volume: 434
Issue: 1
Pages: 102-9
•
•
•
•
•
Publication
16269825 | J:107566
First Author: Shih DM
Year: 2006
Journal: J Lipid Res
Title: A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids.
Volume: 47
Issue: 2
Pages: 384-92
•
•
•
•
•
Publication
32712104 | J:306200
First Author: Ramos Pittol JM
Year: 2020
Journal: Gastroenterology
Title: FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs.
Volume: 159
Issue: 5
Pages: 1853-1865.e10
•
•
•
•
•
Publication
22178739 | J:179375
First Author: Li G
Year: 2012
Journal: Toxicol Appl Pharmacol
Title: A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor.
Volume: 258
Issue: 2
Pages: 268-74
•
•
•
•
•
Publication
28505368 | J:253857
First Author: Takahashi S
Year: 2017
Journal: Toxicol Sci
Title: Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.
Volume: 158
Issue: 2
Pages: 334-346
•
•
•
•
•
Publication
16327028 | J:107554
First Author: Marschall HU
Year: 2006
Journal: J Lipid Res
Title: Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids.
Volume: 47
Issue: 3
Pages: 582-92
•
•
•
•
•
Publication
17624466 | J:126534
First Author: Jansen PL
Year: 2007
Journal: J Hepatol
Title: Endogenous bile acids as carcinogens.
Volume: 47
Issue: 3
Pages: 434-5
•
•
•
•
•
Publication
37077819 | J:345688
 
First Author: Li H
Year: 2023
Journal: Front Pharmacol
Title: Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo.
Volume: 14
Pages: 1148737
•
•
•
•
•
Publication
24954587 | J:309810
First Author: Degirolamo C
Year: 2015
Journal: Hepatology
Title: Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
Volume: 61
Issue: 1
Pages: 161-70
•
•
•
•
•
Publication
16224116 | J:106039
First Author: van Erpecum KJ
Year: 2006
Journal: J Lipid Res
Title: Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function.
Volume: 47
Issue: 1
Pages: 32-41
•
•
•
•
•
Publication
26811456 | J:230446
First Author: Ho PP
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis.
Volume: 113
Issue: 6
Pages: 1600-5
•
•
•
•
•
Publication
20233723 | J:164561
First Author: Schmidt DR
Year: 2010
Journal: J Biol Chem
Title: Regulation of bile acid synthesis by fat-soluble vitamins A and D.
Volume: 285
Issue: 19
Pages: 14486-94
•
•
•
•
•
Publication
18988759 | J:163803
First Author: Miyata M
Year: 2009
Journal: Drug Metab Dispos
Title: Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.
Volume: 37
Issue: 2
Pages: 338-44
•
•
•
•
•
Publication
28647362 | J:253997
First Author: Liu HM
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Farnesoid X receptor agonist GW4064 ameliorates lipopolysaccharide-induced ileocolitis through TLR4/MyD88 pathway related mitochondrial dysfunction in mice.
Volume: 490
Issue: 3
Pages: 841-848
•
•
•
•
•
Publication
21619550 | J:177893
First Author: Lian F
Year: 2011
Journal: Biochem J
Title: Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.
Volume: 438
Issue: 2
Pages: 315-23
•
•
•
•
•
Publication
23811326 | J:203467
First Author: Li G
Year: 2013
Journal: Toxicol Appl Pharmacol
Title: Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
Volume: 272
Issue: 2
Pages: 299-305
•
•
•
•
•
Publication
28496104 | J:275146
First Author: Sheng L
Year: 2017
Journal: Sci Rep
Title: Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.
Volume: 7
Issue: 1
Pages: 1748
•
•
•
•
•
Publication
28711154 | J:244653
First Author: Jena PK
Year: 2017
Journal: Am J Pathol
Title: Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.
Volume: 187
Issue: 8
Pages: 1800-1813
•
•
•
•
•
Publication
33594777 | J:342689
First Author: Xu Y
Year: 2021
Journal: Cell Prolif
Title: Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis.
Volume: 54
Issue: 4
Pages: e13005
•
•
•
•
•
Publication
34171397 | J:336039
 
First Author: Shen C
Year: 2021
Journal: J Ethnopharmacol
Title: Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Volume: 279
Pages: 114340
•
•
•
•
•
Publication
24037988 | J:328414
First Author: Berrabah W
Year: 2014
Journal: Hepatology
Title: Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).
Volume: 59
Issue: 5
Pages: 2022-33
•
•
•
•
•
Publication
36894566 | J:335706
First Author: Tang B
Year: 2023
Journal: Nat Commun
Title: Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy.
Volume: 14
Issue: 1
Pages: 1305
•
•
•
•
•
Publication
19880446 | J:157169
First Author: Mencarelli A
Year: 2009
Journal: J Immunol
Title: The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
Volume: 183
Issue: 10
Pages: 6657-66
•
•
•
•
•
Publication
25870546 | J:242615
 
First Author: Huang F
Year: 2015
Journal: Front Behav Neurosci
Title: Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior.
Volume: 9
Pages: 70
•
•
•
•
•
Publication
23609136 | J:233250
First Author: Cho SW
Year: 2013
Journal: J Bone Miner Res
Title: Positive regulation of osteogenesis by bile acid through FXR.
Volume: 28
Issue: 10
Pages: 2109-21
•
•
•
•
•
Publication
15558057 | J:94664
First Author: Moschetta A
Year: 2004
Journal: Nat Med
Title: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.
Volume: 10
Issue: 12
Pages: 1352-8
•
•
•
•
•
Publication
38069256 | J:343692
 
First Author: Liu HM
Year: 2023
Journal: Int J Mol Sci
Title: Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice.
Volume: 24
Issue: 23
•
•
•
•
•
Publication
16682417 | J:114858
First Author: Jung D
Year: 2006
Journal: J Biol Chem
Title: Pregnane X receptor is a target of farnesoid X receptor.
Volume: 281
Issue: 28
Pages: 19081-91
•
•
•
•
•
Publication
24291500 | J:211881
First Author: Peng X
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Activation of farnesoid X receptor induces RECK expression in mouse liver.
Volume: 443
Issue: 1
Pages: 211-6
•
•
•
•
•
Publication
36209823 | J:331081
First Author: Wang XX
Year: 2022
Journal: J Biol Chem
Title: The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice.
Volume: 298
Issue: 11
Pages: 102530
•
•
•
•
•
Publication
30803859 | J:291563
First Author: Kong B
Year: 2019
Journal: Dig Liver Dis
Title: FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury.
Volume: 51
Issue: 4
Pages: 570-576
•
•
•
•
•
Publication
17440045 | J:121842
First Author: Hubbert ML
Year: 2007
Journal: Mol Endocrinol
Title: Regulation of hepatic Insig-2 by the farnesoid X receptor.
Volume: 21
Issue: 6
Pages: 1359-69
•
•
•
•
•
Publication
25363753 | J:221989
First Author: Deuschle U
Year: 2015
Journal: Int J Cancer
Title: The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein.
Volume: 136
Issue: 11
Pages: 2693-704
•
•
•
•
•
Publication
22661717 | J:188851
First Author: Cyphert HA
Year: 2012
Journal: J Biol Chem
Title: Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.
Volume: 287
Issue: 30
Pages: 25123-38
•
•
•
•
•
Publication
15590640 | J:105051
First Author: Li J
Year: 2005
Journal: J Biol Chem
Title: Regulation of complement C3 expression by the bile acid receptor FXR.
Volume: 280
Issue: 9
Pages: 7427-34
•
•
•
•
•
Publication
29929982 | J:270389
First Author: Liu X
Year: 2018
Journal: J Biol Chem
Title: Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1.
Volume: 293
Issue: 33
Pages: 12759-12769
•
•
•
•
•
Publication
36162519 | J:330709
First Author: Liu X
Year: 2022
Journal: J Lipid Res
Title: Hepatic Deletion of X-Box Binding Protein 1 in FXR Null Mice Leads to Enhanced Liver Injury.
Volume: 63
Issue: 11
Pages: 100289
•
•
•
•
•
Publication
37942583 | J:355064
First Author: Wang Q
Year: 2023
Journal: Gut Microbes
Title: Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling.
Volume: 15
Issue: 2
Pages: 2274124
•
•
•
•
•
Publication
20957146 | J:274220
 
First Author: Weaver BP
Year: 2010
Journal: PLoS One
Title: Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration.
Volume: 5
Issue: 10
•
•
•
•
•
Publication
30967475 | J:280520
First Author: Peng Z
Year: 2019
Journal: J Biol Chem
Title: Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
Volume: 294
Issue: 21
Pages: 8529-8542
•
•
•
•
•
Publication
16002565 | J:104772
First Author: Zollner G
Year: 2005
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Volume: 289
Issue: 5
Pages: G798-805
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom